Ethigen's AL-721 to be renamed
Executive Summary
Egg lecithin nutritional supplement, current under evaluation at NIH as a potential AIDS therapy, will be renamed by Ethigen "to end confusion created by bootleggers selling imitation products," firm reports in press release. FDA has asked the company to rename its nutritional product in order to avoid an implied drug claim. The new name has not yet been selected.